Testing the safety of a new study drug in healthy people
Part of Infections, Kidney & urinary clinical trials.
This study tests a new medicine called TUL108 in a small group of healthy people to see if it is safe and how the body handles it. You would receive either one dose or multiple doses of the medicine or a placebo, and your health will be closely monitored.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 45 years old.
- Your weight must be at least 50 kg (for men) or 45 kg (for women), with a body mass index between 19 and 27.
- You must be in good general health, with no major medical conditions or abnormal lab results.
- If you could become pregnant (or your partner could), you must use highly effective birth control during the study and for 3 months after the last dose.
- You must be willing to receive an injection and have blood drawn multiple times.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is a Phase 1 safety study testing a new investigational drug in healthy volunteers with no serious medical conditions. Researchers will give some participants the drug and others a placebo (inactive treatment) to see how safe the drug is and how the body responds to it.
This study tests a new investigational medicine in healthy adults to see how safe it is and how the body processes it. It is a first-in-human trial, so it is looking for volunteers who are generally well and have normal immune function.
This study tests a new medication (UI087) in healthy volunteers to see how safe it is and how the body processes it, compared to taking three separate medicines together. It's an early-phase trial that may help future patients with a similar treatment option.
This study tests how a new medicine, PF-08065010, is handled by the body and how safe it is in healthy adults. It helps researchers find the right dose for future studies.
This study tests an experimental antibiotic called BWC0977 to see if it is safe and well-tolerated when given as single and multiple doses. It is for healthy volunteers to understand how the drug behaves in the body before moving to patient trials.
This study looks at complicated urinary tract infections (UTIs), which are infections in the urinary system that happen when there is an underlying issue like a urinary catheter, blockage, or other urinary tract problem. The trial aims to gather information to better understand and treat these infections.
Hear when a new Complicated Urinary Tract Infections(cUTI) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.